Literature DB >> 7726818

Differential effects of methylphenidate and self-reinforcement on attention-deficit hyperactivity disorder.

O Ajibola1, P W Clement.   

Abstract

Six boys aged 9 to 12 years attended a tutoring class focusing on reading for 30 minutes each morning. The investigators employed a modified Latin-square design in which each child began with a 5-day baseline phase followed by six 10-day treatment phases that used drug placebo, noncontingent reinforcers, 0.3 mg/kg methylphenidate, 0.7 mg/kg methylphenidate, and self-reinforcement in various combinations. Amount of academic performance was the major measure of outcome and the target behavior of self-reinforcement. Drug placebo and noncontingent reinforcers had no systematic impact. Methylphenidate had differential effects across the recorded behaviors. Self-reinforcement improved the target behavior; the mean effect size for self-reinforcement was 2.66. The combined effects of methylphenidate and self-reinforcement on academic performance were greater than either of the treatments given alone (mean effect size = 2.89).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7726818     DOI: 10.1177/01454455950192004

Source DB:  PubMed          Journal:  Behav Modif        ISSN: 0145-4455


  3 in total

Review 1.  Interventions to address the academic impairment of children and adolescents with ADHD.

Authors:  Veronica L Raggi; Andrea M Chronis
Journal:  Clin Child Fam Psychol Rev       Date:  2006-06

Review 2.  The ethics of elective psychopharmacology.

Authors:  Ahmed D Mohamed; Barbara J Sahakian
Journal:  Int J Neuropsychopharmacol       Date:  2011-03-14       Impact factor: 5.176

Review 3.  How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis.

Authors:  Vibhore Prasad; Ellen Brogan; Caroline Mulvaney; Matthew Grainge; Wendy Stanton; Kapil Sayal
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-11-21       Impact factor: 4.785

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.